HOME >> MEDICINE >> NEWS
Positive study results for methylphenidate transdermal system

Philadelphia, US October 24, 2005 Shire announced at a major medical meeting in Toronto, Canada, that its investigational methylphenidate transdermal system (MTS) demonstrated statistically significant reductions in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) and was generally well tolerated in patients aged 6 to 12 in two clinical trials.

"Children with ADHD must cope with symptoms throughout the day and in a variety of environments, such as in the classroom, during after-school activities, or while at home," explained Sharon Wigal, Ph.D., associate clinical professor of Pediatrics at the University of California, Irvine Child Development Center. "While oral methylphenidate has long been a first-line treatment for patients with ADHD symptoms, if approved, this transdermal patch formulation would provide health care professionals and parents the first and only non-oral medication for children with the disorder."

The MTS patch was developed by Noven Pharmaceuticals, Inc. and combines the active ingredient of methylphenidate with Noven's patented DOT Matrix transdermal technology. This transdermal delivery system was designed to provide continuous medication release throughout the day. The transdermal system releases medication that passes through the skin and directly into the blood stream. The patch is water-resistant.

Data from phase II and phase III clinical trials presented Thursday and Friday in Toronto demonstrated statistically significant improvements in the primary and secondary endpoints analyzed for children treated with MTS compared to children treated with placebo.

The phase II analog classroom study included 79 children with ADHD. The patch was worn for nine hours, and efficacy was assessed throughout the day for twelve hours. MTS demonstrated statistically significant improvement over placebo on the measures tested. Behavior, which was measured using the Swanson, Kotkin, Agler, M-Flynn,
'"/>

Contact: Matthew Cabrey
1-484-595-8248
Porter Novelli
24-Oct-2005


Page: 1 2

Related medicine news :

1. Positive results more likely from industry-funded breast cancer trials
2. M. D. Anderson reports first drug activity in T315I-Positive CML, ALL and JAK-2-Positive MPD
3. Positive parenting helps encourage healthy sun habits in children
4. Positive results for ACRUXs lead product in US Phase 3 trial
5. Positive outcome of Medicare drug benefit
6. Positive study results for methylphenidate transdermal system
7. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. New study shows promise in reducing surgical risks associated with surgical bleeding
10. New study counts the economic cost of persistent pain in Australia
11. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/2/2018)... ... September 02, 2018 , ... Eaton Hotel ... change. The hotel itself, which opened this week, inspires creativity and innovation among ... more. , Eaton Hotel DC currently features 209 hotel rooms, a wellness center, ...
(Date:9/1/2018)... AUSTIN, Texas (PRWEB) , ... September 01, 2018 ... ... health event proclaimed by the International Veterinary Academy of Pain Management (IVAPM) that ... Texas Veterinary Medical Association (TVMA) is partnering with IVAPM by educating pet owners ...
(Date:8/31/2018)... ... August 31, 2018 , ... The social impact documentary feature ... Psychology Professor and NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has been ... Action on Film International Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film Festival, ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... of South Jersey Gastroenterology for another year. Dr. Savon has been active in ... the leaders in comprehensive care for all gastrointestinal diseases and disorders for the ...
(Date:8/29/2018)... ... August 29, 2018 , ... Shady Grove Fertility (SGF), ... announced that they will be relocating two of their offices this September. Their ... just a few miles away, located on the campus of UPMC PinnacleHealth Fredericksen Outpatient ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... ... September 14, 2018 , ... Harris Teeter ... families affected by Hurricane Florence. , Throughout the month of September, the company ... amount, or round up their transaction to the nearest dollar to help support ...
(Date:9/13/2018)... ... , ... Dr. Rod J. Rohrich is pleased to announce that registration is ... experts from around the world, will take place from March 22nd and 23rd, 2019. ... anatomy to complex surgical procedures and detailed analysis of revision rhinoplasty . Formats ...
(Date:9/13/2018)... , ... September 13, 2018 ... ... or “Company”), a specialist pharmaceutical company focused on developing and commercializing gastrointestinal ... first candidate product. , The U.S. Food and Drug Administration (FDA) and ...
Breaking Medicine Technology:
Cached News: